To: | Genentech, Inc. (docketing-d@gene.com) |
Subject: | U.S. Trademark Application Serial No. 88575791 - PHESGO - TM-40391-US |
Sent: | September 09, 2019 06:45:00 PM |
Sent As: | ecom107@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88575791
Mark: PHESGO
|
|
Correspondence Address: |
|
Applicant: Genentech, Inc.
|
|
Reference/Docket No. TM-40391-US
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: September 09, 2019
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by Shameek Ghose on September 9, 2019, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods and/or services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and/or services are not permitted. 37 C.F.R. §2.71(a).
The identification of goods is amended to read as follows:
Pharmaceutical preparations for the treatment of oncology
See TMEP §§1402.01, 1402.01(e).
/Dawn Han/
Examining Attorney
Law Office 107
(571) 272-0399
dawn.han@uspto.gov